Nicotine addiction remains one of the most persistent public health challenges worldwide, driven by changes in the brain that ...

With climate change and higher incidences of crop diseases, global cocoa production and supply is being threatened. A ...

David Baker's lab at the University of Washington is announcing two major leaps in the field of AI-powered protein design.

The FDA has placed a hold on Denali Therapeutics’ plans to launch a phase 1 rare disease trial, citing concerns about immune ...

Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...

Discover why Denali Therapeutics Inc. earns a Strong Buy with FDA-priority drugs, solid pipeline, and a strong cash position.

Global CRISPR Technology Market OverviewThe global CRISPR technology market is poised for strong expansion, projected to grow at a robust CAGR of approximately 16% over the next five years. This ...

DigestMate (TM) became available to health care practitioners in May 2025 through Microbiome Labs' authorized practitioner network. Beginning Dec. 1, 2025, DigestMate (TM) is available on Amazon. For ...

Hypersensitivity reactions in a mouse model prompted the agency to suspend Denali’s planned Phase I development for DNL952 ...

The Precision Fermentation Market is expanding rapidly as advancements in synthetic biology, growing consumer preference for sustainable and alternative proteins, and increasing investments in ...

In return, Royalty will receive a 9.25% royalty on worldwide sales of tividenofusp alfa from Denali until it reaches three times the amount Royalty has handed to Denali—or, alternatively, 2.5 times ...